Document is current
Any future updates will be listed below
-
Authors
Normandin, Erica
Rudy, Melissa http://orcid.org/0000-0003-0165-5669
Barkas, Nikolaos http://orcid.org/0000-0002-4675-0718
Schaffner, Stephen F. http://orcid.org/0000-0001-6699-3568
Levine, Zoe http://orcid.org/0000-0003-2359-3876
Padera, Robert F. Jr
Babadi, Mehrtash
Mukerji, Shibani S. http://orcid.org/0000-0002-5677-6954
Park, Daniel J. http://orcid.org/0000-0001-7226-7781
MacInnis, Bronwyn L. http://orcid.org/0000-0003-0082-968X
Siddle, Katherine J. http://orcid.org/0000-0002-1799-7295
Sabeti, Pardis C. http://orcid.org/0000-0002-9843-1890
Solomon, Isaac H. http://orcid.org/0000-0003-3432-0902
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | Centers for Disease Control and Prevention (75D30120C09605)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (U19AI110818)
U.S. Department of Health & Human Services | U.S. Food and Drug Administration (HHSF223201810172C)
Howard Hughes Medical Institute
- License Information
-
More Information
Article History
Received: 6 January 2022
Accepted: 17 October 2022
First Online: 2 February 2023
Competing interests
: P.C.S. is a co-founder and consultant at Sherlock Biosciences Inc. and Delve Bio, and is a Board Member of Danaher Corporation; she holds equity in all three companies. She has several patents related to diagnostics, genome sequencing, and informatics, including patents licensed to Sherlock Biosciences. All other authors declare no competing interests.
